Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
10 hedge funds and large institutions have $492K invested in Genetic Technologies Ltd. in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 5 → 10 (+5)
52% more capital invested
Capital invested by funds: $324K → $492K (+$168K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$132K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$30.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$12.3K |
| 4 |
Morgan Stanley
New York
|
+$10.2K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$489 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$116K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $242K | -$116K | -11,388 | -35% |
|
|
SFI
2
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $147K | +$132K | +12,920 | New |
|
|
VF
3
Virtu Financial
New York
| $40K | +$36.1K | +3,538 | New |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $34K | +$30.7K | +3,014 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $14K | +$12.3K | +1,203 | +8,020% |
|
|
6
Morgan Stanley
New York
| $11K | +$10.2K | +999 | New |
|
|
DCM
7
Davis Capital Management
Jacksonville,
Florida
| $2K | – | – | – |
|
|
CG
8
Cutler Group
San Francisco,
California
| $1K | – | – | – |
|
|
CAN
9
Cetera Advisor Networks
El Segundo,
California
| $1K | +$489 | +48 | New |
|
|
RE
10
RBC Europe
London,
United Kingdom
| $46 | – | – | – |
|
GENE Hedge Fund Activity: Q2 2020 in Review
10 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2020, worth a combined $492K — up 52% from $324K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GENE positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna Fundamental Investments, opening a new position worth an estimated $132K. The largest seller was Renaissance Technologies, cutting an estimated $116K.
- 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2020, up from 5 in Q1 2020.
- Funds reported $492K of Genetic Technologies Ltd. stock for Q2 2020, up 52% quarter-over-quarter.
- 5 funds opened new Genetic Technologies Ltd. positions in Q2 2020 and 0 closed out, a net change of +5 holders.
- The largest Genetic Technologies Ltd. buyer in Q2 2020 was Susquehanna Fundamental Investments, an estimated $132K added.
- The largest Genetic Technologies Ltd. seller in Q2 2020 was Renaissance Technologies, an estimated $116K sold.
Based on aggregated 13F filings for Q2 2020.